CLINICAL STUDIES ON AC-1370

Abstract

AC-1370 was used in 10 cases (bronchiectasis 1 case, pneumonia 3 cases, cholecystitis 4 cases, chronic pyelonephritis 1 case and acute pyelonephritis with sepsis in 1 case). Efficacy was evaluated to be excellent in 2 cases, good in 6 cases and poor in 2 cases. AC-1370 was effective in 8 out of 10 cases in total for a rate of effectiveness of 80%. Adverse reaction to AC-1370 consisted of 1 case of skin rash and 1 case of slightly elevated GOT and GPT.